Clinical Trial 40235

share

Long Beach, CA 90806


Study Summary:

PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO DETERMINE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF DNL201 IN SUBJECTS WITH PARKINSON’S DISEASE


Qualified Participants Must:

• Subjects aged 30-75 years, with a clinical diagnosis of Parkinson's disease


Qualified Participants May Receive:

Compensation for time and travel 


Research Site Profile

View Clinic Profile


Study is Available At:

CNS Network
2600 Redondo Ave.
Long Beach, CA 90806
View Clinic Location

 


If you would like to get the phone number or be contacted by the clinical trial representative and live within 50 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.